-
-
-
-
-
-
-
UPDATE: Baird Downgrades Arcturus Therapeutics (ARCT) to Neutral; 'Underwhelming ARCT-021 Phase 1/2 Data'
-
-
-
-
-
-
-
Arcturus Therapeutics (ARCT) Prices 4.12M Share Common Stock Offering at $17/sh
-
-
27,186 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

